生物制剂在嗜酸性粒细胞增多症和嗜酸性粒细胞增多性多发性炎症中的应用。

IF 2.7 3区 医学 Q2 ALLERGY Immunology and Allergy Clinics of North America Pub Date : 2024-08-16 DOI:10.1016/j.iac.2024.07.003
{"title":"生物制剂在嗜酸性粒细胞增多症和嗜酸性粒细胞增多性多发性炎症中的应用。","authors":"","doi":"10.1016/j.iac.2024.07.003","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":54997,"journal":{"name":"Immunology and Allergy Clinics of North America","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis\",\"authors\":\"\",\"doi\":\"10.1016/j.iac.2024.07.003\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":54997,\"journal\":{\"name\":\"Immunology and Allergy Clinics of North America\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.7000,\"publicationDate\":\"2024-08-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Immunology and Allergy Clinics of North America\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0889856124000523\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunology and Allergy Clinics of North America","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0889856124000523","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0

摘要

嗜酸性粒细胞增多综合征(HES)和嗜酸性粒细胞肉芽肿伴多血管炎(EGPA)是由血液和组织中的嗜酸性粒细胞增多以及异质性临床表现所定义的复杂疾病。一直以来,这两种疾病的主要治疗方法是全身使用糖皮质激素。然而,最近出现了直接或间接针对嗜酸性粒细胞的生物制剂,这为我们提供了新的途径,可在减少毒性的同时提高疗效。在本文中,我们总结了支持在 HES 和/或 EGPA 中使用特定生物制剂的证据,并提供了在患者中临床使用这些药物的框架。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Biologics in Hypereosinophilic Syndrome and Eosinophilic Granulomatosis with Polyangiitis
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
5.40
自引率
3.80%
发文量
90
审稿时长
>12 weeks
期刊介绍: Immunology and Allergy Clinics of North America updates you on the latest trends in patient management; keeps you up to date on the newest advances; and provides a sound basis for choosing treatment options. Each issue focuses on a single topic in immunology and allergy and is presented under the direction of an experienced guest editor. Topics include allergens, immunotherapy, anaphylaxis, asthma, drug allergy, eosinophilrelated disorders, food allergy, immunodeficiency states (non-HIV), basic science, mast cell disorders, rhinitis and sinusitis, and urticaria and angioedema. Immunology and Allergy Clinics of North America is published four times each year, in February, May, August, and November.
期刊最新文献
Contents Asthma Biologics Real-World Studies of Biologics for the Treatment of Moderate-to-Severe Asthma Biologics in Allergic/Immunologic Conditions Copyright
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1